Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $81.79 as of Feb 12th. NVO’s trailing and forward P/E were 26.01 and 21.51 respectively according to Yahoo Finance.

32 Countries with the Highest Rates of Diabetes

Pixabay/Public Domain

Novo Nordisk (NVO) remains a dominant force in diabetes and obesity treatments, yet the stock is currently trading below its fair value. Despite a recent...